$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
At what stage of myeloma do you need to take pomalidomide?
2026-02-01 22:25:32
Check Details
Effects of Trientine and its selling price
2026-02-01 22:25:32
Check Details
Latest news on when mirikizumab will be launched in China
2026-02-01 22:25:32
Check Details
What are the requirements for the storage conditions of selumetinib/coceyu?
2026-02-01 22:25:32
Check Details
Lorlatinib/Lorlatinib is a drug from which company?
2026-02-01 22:25:32
Check Details
Information on the launch of Cabozantinib
2026-02-01 22:25:32
Check Details
What is the mechanism of action of bosutinib/bosutinib?
2026-02-01 22:25:32
Check Details
What diseases does Upatinib/Ruifu Tablets mainly treat and who is it suitable for?
2026-02-01 22:25:32
Check Details
Analyze the mechanism of action and pharmacology of Teritusumab/Telivac
2026-02-01 22:25:32
Check Details
Price of pomalidomide 1mg and 4mg
2026-02-01 22:25:32
Check Details
FDA approves Tarlatamab-Imdelltra for the treatment of extensive-stage small cell lung cancer (ES-SCLC)
2026-02-01 22:25:32
Check Details
Can domestic selumetinib be successfully launched in 2026? Forecast of the market impact of cobimetinib
2026-02-01 22:25:32
Check Details
1
2
...
2448
2449
2450
2451
2452
2453
2454
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
2
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
3
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
4
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
5
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
6
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
7
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
8
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
9
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
10
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
11
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
12
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring